Conplastic FVB/N-mt129S6/SvEvTac mice: A new tool for cancer research
PLOS One · 2026
DOI: 10.1371/journal.pone.0341557 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Artiom Gruzdev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive & Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, North Ca…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Mitochondrial Proton-Translocating ATPases. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences, Molecular Genomics Core, Comparative Medicine Branch Animal Research Support Core.
Abstract (Originalsprache)
FVB/N mice, which are commonly used for cancer studies, have accelerated onset of endometrial cancer following developmental estrogenic chemical exposure. These mice also have a polymorphism in the mitochondrial gene, mt-Atp8 , leading to increased production of reactive oxygen species. We hypothesized that this polymorphism contributes to the enhanced endometrial cancer phenotype in FVB/N mice. To test this idea, we generated conplastic FVB/N-mt129S6/SvEvTac mice (FVB/N nuclear genome; 129S6/SvEvTac mitochondria: FVB/N-mt129). The impact of 129S6 versus FVB/N mitochondrial genomes on endometrial cancer development following neonatal exposure to the xenoestrogen, diethylstilbestrol, was tested by comparing the cancer phenotypes of FVB/N mice to FVB/N-mt129 mice. There was no difference in cancer incidence regardless of mitochondria source, but cancer grade was higher in the conplastic strain. Additionally, while the FVB/N genetic background is considered non-permissive for generation of pluripotent mouse embryonic stem cells, blastocysts from the conplastic background readily generated mouse embryonic stem cell clones that supported gene editing in culture and subsequently generated germline competent chimeric founder mice. FVB/N-mt129 mice are a potentially powerful resource for generating germline competent embryonic stem cells with an FVB/N nuclear genome and for studying cancer phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Reproductive & Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, North Carolina, United States of America.
- Epigenetics & RNA Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, United States of America.
- Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
ORCID-Profile: Artiom Gruzdev, Carmen J Williams
Förderung
- Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences
- Molecular Genomics Core
- Comparative Medicine Branch Animal Research Support Core
Zitieren
APA
Gruzdev, A., Jefferson, W. N., Hagler, T. B., Scott, G. J., Ray, M. K., Muse, G. W., Sellers, R. S., & Williams, C. J. (2026). Conplastic FVB/N-mt129S6/SvEvTac mice: A new tool for cancer research. PLOS One. https://doi.org/10.1371/journal.pone.0341557
Vancouver
Gruzdev A, Jefferson WN, Hagler TB, Scott GJ, Ray MK, Muse GW, et al. Conplastic FVB/N-mt129S6/SvEvTac mice: A new tool for cancer research. PLOS One. 2026. doi:10.1371/journal.pone.0341557
BibTeX
@article{Gruzdev2026,
author = {Gruzdev, Artiom and Jefferson, Wendy N and Hagler, Thomas B and Scott, Gregory J and Ray, Manas K and Muse, Ginger W and Sellers, Rani S and Williams, Carmen J},
title = {Conplastic FVB/N-mt129S6/SvEvTac mice: A new tool for cancer research},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0341557}
}
EUVIMED